AXCELIS ANNOUNCES MULTIPLE SHIPMENTS OF PURION H200 SiC POWER SERIES IMPLANTERS AND CLOSURE OF PURION XE SiC EVAL TOOL

Rhea-AI Summary

Axcelis Technologies (Nasdaq: ACLS) announced follow-on shipments of the Purion H200 SiC Power Series™ high current implanters to a major power device chipmaker in Asia and Europe during Q3 and Q4. Additionally, the company closed a Purion XE Power Series SiC high energy implanter evaluation for a new European customer. These systems will aid in high-volume production of SiC power devices for the automotive market. The SiC power device market is projected to grow at a 30% CAGR from 2019 to 2025, indicating strong demand for advanced semiconductor solutions.

Positive

• Follow-on shipments of Purion H200 SiC Power Series implanters boost revenue potential.
• New customer acquisition in Europe enhances market presence.
• Strong market growth forecast for SiC power devices at 30% CAGR through 2025.

Negative

• None.

BEVERLY, Mass., Jan. 6, 2022 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced follow on shipments in the third and fourth quarters of the Company's Purion H200 SiC Power Series™ high current implanters to a leading power device chipmaker. The shipments went to multiple fabs located in Asia and Europe.  In the fourth quarter Axcelis also successfully closed a Purion XE Power Series SiC high energy implanter evaluation for a new customer penetration in Europe. The systems at both customers will be used in high volume production of SiC power devices supporting automotive device markets.

AXCELIS ANNOUNCES MULTIPLE SHIPMENTS OF PURION H200 SiC POWER SERIES IMPLANTERS AND CLOSURE OF PURION XE SiC EVAL TOOL

Executive Vice President of Product Development, Bill Bintz, commented, "Increasing automotive power device content is fueling particularly high growth in the power market.  Currently, the SiC Power Device market is forecast to grow with a CAGR of 30% from 2019 to 2025. Device fabrication in this segment requires high implant capital intensity for processes that require higher energy implants and higher energy high dose implants. The Purion product portfolio is uniquely positioned to cover all current and emerging implant applications for this market segment. We look forward to continuing to support our customers' goals to improve power device performance and expand manufacturing capacity."

About Axcelis:
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for 40 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

CONTACTS:
Maureen Hart (editorial/media) 978.787.4266
Doug Lawson (investor relations) 978.787.9552

View original content to download multimedia:https://www.prnewswire.com/news-releases/axcelis-announces-multiple-shipments-of-purion-h200-sic-power-series-implanters-and-closure-of-purion-xe-sic-eval-tool-301454953.html

SOURCE Axcelis Technologies, Inc.

FAQ

What are the recent shipments announced by Axcelis Technologies (ACLS)?

Axcelis announced follow-on shipments of Purion H200 SiC Power Series high current implanters to a leading power device chipmaker in Asia and Europe.

What is the relevance of the Purion XE Power Series evaluation for ACLS?

The successful closure of Purion XE Power Series SiC high energy implanter evaluation indicates new customer penetration in Europe.

How is the SiC power device market projected to grow?

The SiC power device market is forecasted to grow at a CAGR of 30% from 2019 to 2025.